NSCLC (either pathology proven or sufficient clinical suspicion to be treated as NSCLC), referred for palliative radiotherapy of at least the primary tumor site.
Stage 2-4
WHO performance score 0-2.
Provision of signed, written and dated IC prior to any study specific procedures.
You may not be if
Interstitial lung disease
Treatment with vascular endothelial growth factor receptor (VEGFR) inhibitors
Prior thoracic radiotherapy (\>20 Gy EQD2 a/b 3) overlapping with the current planning target volume
